Influenza/RSV/COVID-19? Unique new tests help to detect it
Respiratory viruses will stay with us forever
The Influenza, RSV and COVID-19 viruses will probably be a part of our life to a varying extent every year. Influenza is by far the most widespread virus globally with 1 billion people infected every year, five times the volume of COVID-19 infections on average. RSV is especially dangerous for children and the elderly. It is a major challenge to protect societies from these viruses. A new generation of respiratory antigen self-tests under the RapiChek brand umbrella will support millions in tackling this challenge in Europe and globally.
RapiChek supplies select partners with its unique Influenza A/B/ RSV/ COVID-19 combo test
Since symptoms of the top three respiratory viruses have become very similar, one single COVID-19 test is usually not sufficient anymore to ensure that we and our beloved ones will feel safe. The RapiChek self-test portfolio provides a differentiated result within 15 minutes. Patients will find out whether they have Influenza A, Influenza B, COVID-19 or RSV viruses or even more out of these. This information can be crucial to start the right treatment and avoid unnecessary complications. Distributors and their clients including pharmacies, drug stores, supermarkets, local and national governments have a useful and innovative product from now on to fight against the top viruses with products coming directly from the factories.
The next big opportunity for distributors, pharmacies, mass market channels
Innovators have a good chance to stay ahead of others. RapiChek will work with one or two innovative master distributors in each country in the EU / UK who share the vision that these combined test solutions mean the "future of rapid self-testing".
RapiChek ensures a safe and successful market presence for its distributors and supports them by marketing/PR content and know how in addition to favourable payment and delivery terms.
The RapiChek brand is a registered trademark of UK based The Global Wellbeing Society Ltd. (GWBS Ltd.), its warehouse in continental Europe can be found in the heart of Europe within 48 hours driving distance to any EU city, operated by A-Lab Pharma.
RapiChek's unique portfolio of combo & single antigen tests
Influenza A/B / COVID-19 / RSV Antigen Nasal Self-test
For symptomatic or suspect screening
- After the onset of one or more joint symptoms of the three respiratory viruses
- Of particular importance for children, participating in communities, family members with children, their contacts and children's contacts, the elderly and groups at high risk of health problems, especially, if their contacts
For symptomatic or suspect screening
- After the onset of one or more joint symptoms of the three respiratory viruses
- Of particular importance for children, participating in communities, family members with children, their contacts and children's contacts, the elderly and groups at high risk of health problems, especially, if their contacts show symptoms
- Also, for those who have been in contact with any of the above persons, and particularly if one or more of the three respiratory viruses have been present in these persons.
For preventive respiratory infection screening
- For the above groups at any time, but especially before and after family, social and public events to avoid asymptomatic infection transmission.
Influenza A/B / COVID-19 Antigen Nasal Self-test
For symptomatic or suspect screening
- If you experience one or more of the combined symptoms of influenza A/B and SARS-Cov-2, but none of the RSV-only symptoms or those common for all three viruses, so the possibility of infection with the RSV virus is low or non-existent.
- For people who have not been in contact with children, participating
For symptomatic or suspect screening
- If you experience one or more of the combined symptoms of influenza A/B and SARS-Cov-2, but none of the RSV-only symptoms or those common for all three viruses, so the possibility of infection with the RSV virus is low or non-existent.
- For people who have not been in contact with children, participating in communities, their parents or the elderly in the past 8 days and there is little or no chance of catching or transmitting RSV.
For preventive respiratory infection screening
- For the above groups before and after family, social and public events, and to avoid asymptomatic transmission when the possibility of RSV infection is minimal or can be excluded due to the known network of contacts and social activity of the associated group members.
COVID-19 Antigen Nasal Self-test
COVID-19 Antigen Nasal Self-test
For symptomatic or suspect screening
- For people who only have symptoms typical of SARS-CoV-2 infection, or who have been in contact with people infected with SARS-CoV-2 and whose symptoms rule out the possibility of the other two main viral infections, RSV and Influenza.
- Those who have neither been in close contact with children, participat
For symptomatic or suspect screening
- For people who only have symptoms typical of SARS-CoV-2 infection, or who have been in contact with people infected with SARS-CoV-2 and whose symptoms rule out the possibility of the other two main viral infections, RSV and Influenza.
- Those who have neither been in close contact with children, participating in community activities, nor with their parents or the elderly in the past 8 days, so the possibility of contacting RSV or influenza is low or non-existent. However, they consider that an exposure to COVID-infected persons cannot be ruled out in the past 4 days.
For COVID-19 only preventive screening
- To avoid transmission of an asymptomatic infection to anybody or identifying a potential infection transmitted from those who have a low or no chance of having been infected with RSV or influenza in the past 8 days, since they have not been in contact with children participating in community activities, their parents and the elderly, but who have some chance of having an asymptomatic COVID-infection based on heir contact tracing.
A-Lab Pharma in the news
